Amber List
RDNT
RadNet, Inc.
Healthcare · Diagnostics & Research · mid-cap ($4.3B)
-37.8%
from rolling 252-day high of $85.84 set 2025-11-25 · 170d ago
Current
$53.43
Decline depth
-37.8%
Decline σ
7.4σ
TFC
4/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Structural break signals

RDNT qualifies for the Amber List on decline depth.

Decline depth
-37.8%
From rolling 252-day high of $85.84, 170d ago. Past the 30% Amber threshold.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 4/5 Amber threshold.
Decline sigma
7.4σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (2.24% per day). Past the ≥6σ Amber threshold.

The structural read

What price action says about RDNT.

RDNT qualifies for the Amber List on decline depth — down -37.8% from its rolling 252-day high.

Cross-confirmation: also showing 4/5 bearish time frames.

Cross-confirmation: decline sigma also reads 7.4σ over 5 bars.

Earnings on file: 2026-03-02. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $45.00 20.6% of range 52W high $85.84

Sector context · Healthcare

182 other Healthcare tickers are on Broken Stocks.

93 Red List
42 Amber
47 Watch
-35.8% Median decline

Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →

Questions about RDNT

What people ask.

Why is RDNT on Broken Stocks?

RDNT qualifies for the Amber List on decline depth. It is down -37.8% from its rolling 252-day high of $85.84, set on 2025-11-25 — 170d ago.

Is RDNT a falling knife?

Not by the strict technical definition. RDNT is down -37.8% from its 52-week high, but that high was set 170d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. RDNT is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is RDNT a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is RDNT trading inside its 52-week range?

At $53.43, RDNT sits 20.6% of the way from its 52-week low ($45.00) to its 52-week high ($85.84). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has RDNT been declining?

The current 37.8% decline accrued over 170d, which annualizes to roughly -81.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does RDNT compare to its sector?

There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — RDNT's decline is deeper than the sector median.

Does RDNT's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-03-02) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.